Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adeno-Associated Vector (Type 8)-Mediated Expression of Soluble Flt-1 Efficiently Inhibits Neovascularization in a Murine Choroidal Neovascularization Model

6 Jan 2010

Abstract excerpt

To assess the feasibility of a gene therapeutic approach to treating choroidal neovascularization (CNV), we generated a recombinant adeno-associated viral (AAV) vector (type 8) encoding soluble Flt-1 (AAV-sflt-1), and determined its ability to inhibit angiogenesis. When we treated human umbilical vein endothelial cells (HUVECs) with the supernatant of cells transduced with AAV-sflt-1 or AAV-EGFP (control), we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation and Thrombosis Mechanisms
Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20053138
DOI: 10.1089/hum.2009.153

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adeno-Associated Vector (Type 8)-Mediated Expression of Soluble Flt-1 Efficiently Inhibits Neovascularization in a Murine Choroidal Neovascularization ModelPMID 20053138Read ↗

Gene therapy for age-related macular degenerationSemantic proximity Read ↗

AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular DegenerationSemantic proximity Read ↗

Targeting vascular endothelial growth factor using retinal gene therapySemantic proximity Read ↗

Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal NeovascularizationSemantic proximity Read ↗

Inhibition of Retinal Neovascularization by Intraocular Viral-Mediated Delivery of Anti-angiogenic AgentsSemantic proximity Read ↗

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1Semantic proximity Read ↗

rAAV.sFlt-1 Gene Therapy Achieves Lasting Reversal of Retinal Neovascularization in the Absence of a Strong Immune Response to the Viral VectorSemantic proximity Read ↗

Marked inhibition of retinal neovascularization in rats following soluble‐flt‐1 gene transferSemantic proximity Read ↗

CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degenerationSemantic proximity Read ↗

Inhibition of Choroidal Neovascularization via Brief Subretinal Exposure to a Newly Developed Lentiviral Vector Pseudotyped with Sendai Viral Envelope ProteinsSemantic proximity Read ↗

Gene therapy for ocular angiogenesisSemantic proximity Read ↗

Subretinal AAV delivery of RNAi-therapeutics targeting VEGFA reduces choroidal neovascularization in a large animal modelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.